Загрузка...
The interaction between RUNX2 and core binding factor beta (CBFβ) as a potential therapeutic target in canine osteosarcoma
Osteosarcoma remains the most common primary bone tumor in dogs with half of affected dogs unable to survive one year beyond diagnosis. New therapeutic options are needed to improve outcomes for this disease. Recent investigations into potential therapeutic targets have focused on cell surface molec...
Сохранить в:
| Опубликовано в: : | Vet Comp Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7233265/ https://ncbi.nlm.nih.gov/pubmed/31381810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12526 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|